Opthea’s lead product candidate, sozinibercept, is being evaluated in two fully enrolled pivotal Phase 3 clinical trials (COAST, NCT04757636, and ShORe, NCT04757610) for use in combination with ...
New System Enhances Surgical Efficiency and Provides Versatile Solutions for Complex Spine ProceduresBELGRADE, MT / ACCESSWIRE / September 23, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), ...
Once the job in hand was completed, he would slide against you, purring softly, maximising his chance of receiving a stroke along his long, muscular back. As cats go, he was amongst the coolest ...
Two University of Wyoming faculty members will study how to understand the microcircuit changes that occur in the brain’s prefrontal cortex during normal aging as well as disease progression in ...